FDA revamping pregnancy/lactation Rx drug label warnings
This article was originally published in Scrip
Executive Summary
The FDA is revamping the way risk information is communicated in prescription drug labeling for women who are pregnant or breastfeeding – tossing out its current five-letter category system, which it called "overly simplistic" and something that is often misinterpreted.